Pippa’s research experience started in pharmaceutical industry in clinical research and having gained her Masters in Health Economics in the early 1990’s moved into the field of health economics and outcomes research. Her current research expertise covers economic analysis, priority setting, health care policy and in undertaking research and economic evaluation using observational data. A founding director, Pippa established Fourth Hurdle Consulting Ltd. – a health economics consultancy - in 1999 together with David Grant and Adam Lloyd. Having ensured the successful integration of Fourth Hurdle into IMS Health when purchased in 2008, Pippa followed a long held ambition to complete a PhD in Health Economics (soon to be handed in) and joined Swansea University. Here she is Acting Head and a Director of the Swansea Centre for Health Economics – a health economics and outcomes research center with a particular expertise in health policy and ‘real world’ routine data analysis. Pippa also acts as a deputy Health Economist for the All Wales Medicines Strategy Group and is the health economist for the associated New Medicines Group.